Cite
HARVARD Citation
Theurey, P. et al. (2022). Phase 2 trial with imeglimin in patients with Type 2 diabetes indicates effects on insulin secretion and sensitivity. Endocrinology, diabetes & metabolism. 5 (6), p. n/a. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Theurey, P. et al. (2022). Phase 2 trial with imeglimin in patients with Type 2 diabetes indicates effects on insulin secretion and sensitivity. Endocrinology, diabetes & metabolism. 5 (6), p. n/a. [Online].